Recordati to acquire EUSA Pharma to expand rare disease products portfolio
EUSA Pharma’s product portfolio includes Qarziba, Sylvant, Fotivda and Caphosol.
Italy
Latest in
Italy
Italy approves Pfizer and BioNTech’s Covid-19 vaccine for children
The dosage for children is indicated to be a third of the authorised 30µg dose given to adults and adolescents.
Italy gives approval to trial osteoporosis drug for Covid-19 treatment
The Italian Medicines Agency (AIFA) has granted approval to conduct human clinical trials on raloxifene, a generic osteoporosis drug to…
Partner content
Medical solutions in primary care and rare diseases
Primary care physicians are qualified to offer care for a comprehensive scope of conditions in their patient population. They maintain…
Merck, contract research firm IRBM partner on coronavirus therapies
Merck (MSD) has collaborated with contract research services company IRBM for the identification and development of new peptide therapeutics that…
Italy researchers claim vaccine neutralises coronavirus in human cells
Scientists at Lazzaro Spallanzani National Institute for Infectious Diseases in Italy have claimed that a vaccine candidate could neutralise coronavirus…
Menarini Group to buy Stemline Therapeutics in deal valued at $677m
Italian pharmaceutical and diagnostics company Menarini Group has signed a definitive agreement to acquire US-based Stemline Therapeutics for up to…
Kamada and Kedrion to develop immunoglobulin product for Covid-19
Biopharmaceutical companies Kamada and Kedrion Biopharma have partnered to develop, manufacture and distribute a human plasma-derived polyclonal immunoglobulin (IgG) product…